Loading...
XSTO
GETI B
Market cap6.81bUSD
Oct 07, Last price  
250.00SEK
1D
-0.24%
1Q
22.97%
Jan 2017
73.61%
Name

Getinge

Chart & performance

D1W1MN
XSTO:GETI B chart
P/E
30.16
P/S
1.95
EPS
8.29
Div yield, %
1.84%
Shrs. gr., 5y
—
Rev. gr., 5y
3.24%
Revenues
34.97b
+0.60%
13,001,000,00016,445,000,00019,272,000,00022,816,000,00022,172,000,00021,854,000,00024,248,000,00025,287,000,00026,669,000,00030,235,000,00029,756,000,00022,495,000,00024,172,000,00026,559,000,00029,819,000,00027,049,000,00028,291,000,00031,827,000,00034,759,000,00034,969,000,000
Net income
2.26b
+37.85%
1,254,000,0001,260,000,0001,523,000,0001,914,000,0002,277,000,0002,529,000,0002,521,000,0002,285,000,0001,433,000,0001,390,000,0001,188,000,0001,376,000,000-967,000,0001,222,000,0003,239,000,0002,970,000,0002,491,000,0002,412,000,0001,638,000,0002,258,000,000
CFO
3.95b
-13.72%
1,504,500,0001,328,000,0001,475,000,0004,000,000,0004,124,000,0003,496,000,0003,687,000,0003,544,000,0003,473,000,0003,458,000,0003,671,000,0002,763,000,0002,503,000,0003,832,000,0007,199,000,0006,560,000,0003,367,000,0002,957,000,0004,577,000,0003,949,000,000
Dividend
Apr 22, 20264.75 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Getinge AB, founded in 1904 and headquartered in Gothenburg, Sweden, is a prominent global supplier of medical technology solutions. The company's extensive portfolio is designed for critical healthcare environments, including operating rooms, intensive care units, and sterile processing facilities. Its operations are divided into three core segments: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers a comprehensive array of specialized equipment and systems. This encompasses advanced solutions for sterile processing and containment, such as sterilizers, washers, isolators, and automated logistic systems. For the life sciences sector, they provide bioreactors, bioprocess control systems, and associated analytics tools. Within acute care and surgical settings, their offerings range from anesthesia machines, specialized monitoring systems, and various disposables, to instruments for cardiac surgery (like beating heart stabilizers), mechanical ventilation products, and extracorporeal life support (ECMO) solutions. Additionally, Getinge provides infrastructure for operating rooms, including lighting, tables, modular systems, and integrated management tools, alongside products for cleaning, disinfection, packaging, and comprehensive sterile supply management. Their product line further extends to diverse catheters (thoracic, endovascular), endoscopic vessel harvesting systems, patient flow and transport solutions, and specialized devices for vascular and cardiothoracic surgery. The company distributes its broad range of products globally through its proprietary sales companies, as well as via agents and distributors, serving markets across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.

Related entities

Parent
Carl Bennet AB
Subsidiaries (3)
Getinge Treasury Ireland Designated Activity Company
MAQUET GmbH
MAQUET Medical Systems AG

Key people

Chairman of the Board · since 2019
Independent Director · since 2007
Independent Director · since 2014
Chief Financial Officer · since 2017
IPO date
Jun 08, 1995
Employees
11,098
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Box 8861
Göteborg, O 402 72
SE
Address
Box 8861
Goteborg, O 402 72
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT